These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 18619820)

  • 1. Emergence of a cefepime- and cefpirome-resistant Citrobacter freundii clinical isolate harbouring a novel chromosomally encoded AmpC beta-lactamase, CMY-37.
    Ahmed AM; Shimamoto T
    Int J Antimicrob Agents; 2008 Sep; 32(3):256-61. PubMed ID: 18619820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of CFE-2, a new plasmid-encoded AmpC β-lactamase from a clinical isolate of Citrobacter freundii.
    Chen CM; Huang M; Wu HJ; Guo MK; Wu LT
    Int J Antimicrob Agents; 2018 Sep; 52(3):421-424. PubMed ID: 29944954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrolysis spectrum extension of CMY-2-like β-lactamases resulting from structural alteration in the Y-X-N loop.
    Dahyot S; Mammeri H
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1151-6. PubMed ID: 22232281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extension of resistance to cefepime and cefpirome associated to a six amino acid deletion in the H-10 helix of the cephalosporinase of an Enterobacter cloacae clinical isolate.
    Barnaud G; Labia R; Raskine L; Sanson-Le Pors MJ; Philippon A; Arlet G
    FEMS Microbiol Lett; 2001 Feb; 195(2):185-90. PubMed ID: 11179650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vivo Evolution of CMY-2 to CMY-33 β-Lactamase in Escherichia coli Sequence Type 131: Characterization of an Acquired Extended-Spectrum AmpC Conferring Resistance to Cefepime.
    Pires J; Taracila M; Bethel CR; Doi Y; Kasraian S; Tinguely R; Sendi P; Bonomo RA; Endimiani A
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7483-8. PubMed ID: 26392491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
    Susić E
    Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to gram-negative organisms due to high-level expression of plasmid-encoded ampC beta-lactamase blaCMY-4 promoted by insertion sequence ISEcp1.
    Nakano R; Okamoto R; Nagano N; Inoue M
    J Infect Chemother; 2007 Feb; 13(1):18-23. PubMed ID: 17334724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Four variants of the Citrobacter freundii AmpC-Type cephalosporinases, including novel enzymes CMY-14 and CMY-15, in a Proteus mirabilis clone widespread in Poland.
    Literacka E; Empel J; Baraniak A; Sadowy E; Hryniewicz W; Gniadkowski M
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4136-43. PubMed ID: 15504832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance to cefepime and cefpirome due to a 4-amino-acid deletion in the chromosome-encoded AmpC beta-lactamase of a Serratia marcescens clinical isolate.
    Mammeri H; Poirel L; Bemer P; Drugeon H; Nordmann P
    Antimicrob Agents Chemother; 2004 Mar; 48(3):716-20. PubMed ID: 14982755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CFE-1, a novel plasmid-encoded AmpC beta-lactamase with an ampR gene originating from Citrobacter freundii.
    Nakano R; Okamoto R; Nakano Y; Kaneko K; Okitsu N; Hosaka Y; Inoue M
    Antimicrob Agents Chemother; 2004 Apr; 48(4):1151-8. PubMed ID: 15047515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of chromosomal qnrB and ampC alleles in Citrobacter freundii isolates from different origins.
    Liao X; Fang L; Li L; Sun J; Li X; Chen M; Deng H; Yang Q; Li X; Liu Y
    Infect Genet Evol; 2015 Oct; 35():214-20. PubMed ID: 26168881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KHM-1, a novel plasmid-mediated metallo-beta-lactamase from a Citrobacter freundii clinical isolate.
    Sekiguchi J; Morita K; Kitao T; Watanabe N; Okazaki M; Miyoshi-Akiyama T; Kanamori M; Kirikae T
    Antimicrob Agents Chemother; 2008 Nov; 52(11):4194-7. PubMed ID: 18765691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterisation of CMY-4, an AmpC-type plasmid-mediated beta-lactamase in a Tunisian clinical isolate of Proteus mirabilis.
    Verdet C; Arlet G; Ben Redjeb S; Ben Hassen A; Lagrange PH; Philippon A
    FEMS Microbiol Lett; 1998 Dec; 169(2):235-40. PubMed ID: 9868767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occurrence of extended-spectrum beta-lactamases among chromosomal AmpC-producing Enterobacter cloacae, Citrobacter freundii, and Serratia marcescens in Korea and investigation of screening criteria.
    Park YJ; Park SY; Oh EJ; Park JJ; Lee KY; Woo GJ; Lee K
    Diagn Microbiol Infect Dis; 2005 Apr; 51(4):265-9. PubMed ID: 15808318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and nucleotide sequence of a Klebsiella oxytoca cryptic plasmid encoding a CMY-type beta-lactamase: confirmation that the plasmid-mediated cephamycinase originated from the Citrobacter freundii AmpC beta-lactamase.
    Wu SW; Dornbusch K; Kronvall G; Norgren M
    Antimicrob Agents Chemother; 1999 Jun; 43(6):1350-7. PubMed ID: 10348751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Origin and evolution of the AmpC beta-lactamases of Citrobacter freundii.
    Barlow M; Hall BG
    Antimicrob Agents Chemother; 2002 May; 46(5):1190-8. PubMed ID: 11959544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitor-sensitive AmpC beta-lactamase variant produced by an Escherichia coli clinical isolate resistant to oxyiminocephalosporins and cephamycins.
    Doi Y; Wachino J; Ishiguro M; Kurokawa H; Yamane K; Shibata N; Shibayama K; Yokoyama K; Kato H; Yagi T; Arakawa Y
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2652-8. PubMed ID: 15215122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two novel CMY-2-type β-lactamases encountered in clinical Escherichia coli isolates.
    Manageiro V; Ferreira E; Pinto M; Fonseca F; Ferreira M; Bonnet R; Caniça M
    Ann Clin Microbiol Antimicrob; 2015 Mar; 14():12. PubMed ID: 25885413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosomally encoded ampC-type beta-lactamase in a clinical isolate of Proteus mirabilis.
    Bret L; Chanal-Claris C; Sirot D; Chaibi EB; Labia R; Sirot J
    Antimicrob Agents Chemother; 1998 May; 42(5):1110-4. PubMed ID: 9593136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended-spectrum beta-lactam resistance due to AmpC hyperproduction and CMY-2 coupled with the loss of OMPK35 in Malaysian strains of Escherichia coli and Klebsiella pneumoniae.
    Palasubramaniam S; Subramaniam G; Muniandy S; Parasakthi N
    Microb Drug Resist; 2007; 13(3):186-90. PubMed ID: 17949305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.